SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,362 | -53.9% | 254,021 | 0.0% | 0.00% | – |
| Q2 2023 | $330,227 | +13.0% | 254,021 | +53.0% | 0.00% | – |
| Q1 2023 | $292,285 | -73.6% | 166,071 | -52.8% | 0.00% | – |
| Q4 2022 | $1,105,503 | +48.4% | 352,071 | +131.5% | 0.00% | – |
| Q3 2022 | $745,000 | -59.1% | 152,071 | -65.4% | 0.00% | -100.0% |
| Q2 2022 | $1,820,000 | +105.9% | 439,687 | +189.1% | 0.00% | – |
| Q1 2022 | $884,000 | -22.3% | 152,071 | +0.2% | 0.00% | – |
| Q4 2021 | $1,138,000 | -16.8% | 151,771 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,367,000 | -24.8% | 151,771 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,817,000 | -7.3% | 151,771 | -3.0% | 0.00% | 0.0% |
| Q1 2021 | $1,960,000 | -17.9% | 156,441 | +2.2% | 0.00% | 0.0% |
| Q4 2020 | $2,388,000 | +101.7% | 153,041 | +22.1% | 0.00% | 0.0% |
| Q3 2020 | $1,184,000 | -9.0% | 125,341 | -13.7% | 0.00% | 0.0% |
| Q2 2020 | $1,301,000 | +40.6% | 145,241 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $925,000 | -23.9% | 145,241 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,216,000 | -7.5% | 145,241 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,314,000 | -21.2% | 145,241 | -6.2% | 0.00% | 0.0% |
| Q2 2019 | $1,668,000 | +22.2% | 154,841 | +8.2% | 0.00% | 0.0% |
| Q1 2019 | $1,365,000 | -16.9% | 143,041 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,642,000 | -32.3% | 143,041 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $2,425,000 | +19.4% | 143,041 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $2,031,000 | -40.5% | 143,041 | -20.4% | 0.00% | -50.0% |
| Q1 2018 | $3,416,000 | +9.3% | 179,803 | -5.7% | 0.00% | 0.0% |
| Q4 2017 | $3,126,000 | +9.3% | 190,583 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,859,000 | +260.1% | 190,583 | +111.2% | 0.00% | +100.0% |
| Q2 2017 | $794,000 | +69.3% | 90,241 | 0.0% | 0.00% | – |
| Q1 2017 | $469,000 | +53.3% | 90,241 | -10.2% | 0.00% | – |
| Q4 2016 | $306,000 | -27.7% | 100,441 | +10.0% | 0.00% | – |
| Q3 2016 | $423,000 | -20.0% | 91,341 | 0.0% | 0.00% | – |
| Q2 2016 | $529,000 | -4.3% | 91,341 | 0.0% | 0.00% | – |
| Q1 2016 | $553,000 | -40.3% | 91,341 | -10.0% | 0.00% | -100.0% |
| Q4 2015 | $927,000 | +54.2% | 101,541 | -4.8% | 0.00% | 0.0% |
| Q3 2015 | $601,000 | -49.2% | 106,641 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,184,000 | -21.8% | 106,771 | +10.6% | 0.00% | 0.0% |
| Q1 2015 | $1,514,000 | +3.1% | 96,571 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,469,000 | +41.0% | 96,571 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,042,000 | -29.4% | 96,571 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,475,000 | -15.5% | 96,571 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $1,746,000 | +46.8% | 96,571 | +12.9% | 0.00% | +100.0% |
| Q4 2013 | $1,189,000 | +32.6% | 85,571 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $897,000 | +32.7% | 85,571 | -1.2% | 0.00% | 0.0% |
| Q2 2013 | $676,000 | – | 86,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |